Health
Neurophet Publishes Clinical Validation Results of 'Neurophet AQUA' in Annals Academy of Medicine Singapore
Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on the 30th that the results of a clinical study validating the clinical efficacy of its brain neurodegeneration imaging analysis software, Neurophet AQUA, in patients with mild cognitive impairment and dementia have been published in the international journal Annals Academy of Medicine Singapore.
About this update from Neurophet, Inc.
[{"type":"text","content":"- Clinical study conducted at the Dementia Research Centre, Nanyang Technological University, Singapore, involving Southeast Asian participants","length":148,"tagName":"p"},{"type":"text","content":"- Expert level accuracy, while significantly reducing analysis time for white matter hyperintensity and gray matter volume","length":122,"tagName":"p"},{"type":"text","content":"SEOUL, South Korea, Sept. 30, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on the 30th that the results of a clinical study validating the clinical efficacy of its brain neurodegeneration imaging analysis software, Neurophet AQUA, in patients with mild cognitive impairment and dementia have been published in the international journal Annals Academy of Medicine Singapore.","length":509,"tagName":"p"},{"type":"image","alt":"Neurophet AQUA is a brain neurodegeneration imaging analysis software.","displaySize":"","headline":null,"caption":"Neurophet AQUA is a brain neurodegeneration imaging analysis software.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":250,"url":"https://media.zenfs.com/en/prnewswire.com/4131230626b31032580d08d3f488d212"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/w6b9GWxV_MPF8PEBFne9zA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ0MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4131230626b31032580d08d3f488d212","width":400,"height":250}},"href":"https://mma.prnewswire.com/media/2784190/Neurophet_AQUA_is_a_brain_neurodegeneration_imaging_analysis_software.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The clinical study was conducted from April 2022 to July 2023 at the Dementia Research Centre of the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. A total of 90 adults from a community-based cohort in Singapore participated in the study, including 30 healthy individuals, 40 patients with mild cognitive impairment, and 20 patients with dementia.","length":380,"tagName":"p"},{"type":"text","content":"To evaluate the clinical efficacy of Neurophet AQUA, the research team analyzed white matter hyperintensities (WMH) and gray matter volume of the participants. The results showed a strong correlation between the ...